Cargando…
Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of Apoptosis
Mutation of the PARK2 gene can promote both Parkinson's Disease and cancer, yet the underlying mechanisms of how PARK2 controls cellular physiology is incompletely understood. Here, we show that the PARK2 tumor suppressor controls the apoptotic regulator BCL-XL and modulates programmed cell dea...
Autores principales: | Gong, Yongxing, Schumacher, Steven E., Wu, Wei H., Tang, Fanying, Beroukhim, Rameen, Chan, Timothy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198112/ https://www.ncbi.nlm.nih.gov/pubmed/28038320 http://dx.doi.org/10.1016/j.neo.2016.12.006 |
Ejemplares similares
-
Regulation of apoptosis by an intrinsically disordered region of Bcl-xL
por: Follis, Ariele Viacava, et al.
Publicado: (2018) -
Apoptosis blocks Beclin 1-dependent autophagosome synthesis – an effect rescued by Bcl-xL
por: Luo, S, et al.
Publicado: (2009) -
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
por: He, Yonghan, et al.
Publicado: (2020) -
Bcl-xL in neuroprotection and plasticity
por: Jonas, Elizabeth A., et al.
Publicado: (2014) -
Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma
por: Adams, Clare M., et al.
Publicado: (2019)